The Spanish Society of Health Informatics acknowledges the results of TartaglIA to transform clinical and healthcare in Spain through Artificial Intelligence

The innovative TARTAGLIA project, led by the technological multinational GMV and supported by a public-private consortium composed of 16 key entities* in the health sector, has far exceeded its main objective: to accelerate clinical and health research through the use of artificial intelligence (AI) to extract valuable information from real patient data, thus facilitating the development of new therapies and improving the accuracy of health care.

One of the most outstanding achievements of the project has been the implementation of advanced models of neural networks and the integration of data from multiple sources, which has allowed, among other things, to reach an impressive accuracy of 80% in the prediction of prostate cancer. This figure not only underlines the potential of AI in diagnosis, but also marks a significant advance in the improvement of personalized medicine.

The impact of TARTAGLIA has been so significant that the Spanish Health Informatics Society (SEIS) has recognized its progress with an honorable mention in its National Health and Informatics Awards held yesterday, chaired by Mónica García Gómez, Minister of Health of Spain. The SEIS has highlighted the consortium's pioneering effort to digitally transform clinical and health research in Spain. The jury highlighted the implementation of a federated network with AI and the use of advanced cryptographic methods, as a crucial advance for the sector. At the award ceremony, representatives of GMV, the Ministry for Digital Transformation and the Galician Health Service collected the award, underlining the value that this project brings to both health professionals and citizens.

TARTAGLIA, launched in 2022, stood out among all the projects presented in the Artificial Intelligence R&D Missions program of the España Digital 2025 agenda, obtaining the highest score. In addition, it has funding from the European Union through the Next Generation EU funds, achieving a budget of more than 7.5 million euros, the largest in its category.

With TARTAGLIA, technology continues to demonstrate its ability to transform the future of health, opening new doors to more precise diagnoses, more effective treatments and an increasingly personalized and accessible medicine.

* The entities that make up the TARTAGLIA consortium are: GMV; Accessible; Barcelona Supercomputing Center - National Supercomputing Center; Dasel; ACE Foundation, Catalan Institute of Applied Neurosciences; Foundation for the Promotion of Health and Biomedical Research of the Valencian Community; Fisabio Foundation; Foundation for the investigation of the University and Polytechnic Hospital La Fe-Comunidad Valenciana; Rioja Health Foundation; I think Pixelabs; Galician Health Knowledge Agency; Complutense University of Madrid; PricewaterhouseCoopers; Vall d'Hebron University Hospital Foundation Research Institute and Veratech.